E747-57 peptide plus synthetic dsRNA vaccine (Mannkind Corp)

N/A

Report date: 2025/04/21 17:03:46

Base Information

Drug NameE747-57 peptide plus synthetic dsRNA vaccine (Mannkind Corp)

Drug Alias Nameprophylactic/therapeutic vaccine (RNA technology/injectable formulation, solid tumors)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMannKind Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMannKind Corp

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A